Covered recipient · General Payments record
KEVIN WATSON
Allopathic & Osteopathic Physicians Pediatrics Pediatric Gastroenterology
General Payments · PY2018–2024
$10,211.24
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $2,000.00 | 1 |
| Food and Beverage | $349.14 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| QOL Medical, LLC | $2,118.59 | 7 |
| GENZYME CORPORATION | $56.46 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $42.21 | 2 |
| ABBVIE INC. | $39.28 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.42 | 1 |
| Mirum Pharmaceuticals, Inc. | $27.22 | 1 |
| Janssen Biotech, Inc. | $21.80 | 1 |
| Avanos Medical | $13.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.14 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106313249 | CMS |
| ABBVIE INC. | $20.14 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106313251 | CMS |
| Avanos Medical | $13.16 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149309639 | CMS |
| GENZYME CORPORATION | $29.08 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139873691 | CMS |
| GENZYME CORPORATION | $27.38 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139873757 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $20.02 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153761534 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $22.19 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153772314 | CMS |
| Janssen Biotech, Inc. | $21.80 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078487198 | CMS |
| Mirum Pharmaceuticals, Inc. | $27.22 | 03/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123323239 | CMS |
| QOL Medical, LLC | $19.02 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147728776 | CMS |
| QOL Medical, LLC | $23.89 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147728778 | CMS |
| QOL Medical, LLC | $20.60 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147728780 | CMS |
| QOL Medical, LLC | $17.58 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147728782 | CMS |
| QOL Medical, LLC | $2,000.00 | 08/26/2024 | Honoraria | Undisputed | 01/23/2026 | 1147728774 | CMS |
| QOL Medical, LLC | $19.63 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147728784 | CMS |
| QOL Medical, LLC | $17.87 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147728786 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.42 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137695258 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.